Developing Countries Vaccine Manufacturers Network

The Developing Countries Vaccine Manufacturers Network (DCVMN) is a voluntary non-partisan

In 2018, DCVMN members supplied more than half of the 2.36 billion doses of vaccines used globally by UNICEF.^[9] In 2019, a survey of 41 DCVMN members assessed their ability to use technology platforms, cell cultures and filling technologies for the manufacture of drug products. DCVMN members reported that they had the capability to supply over 50 distinct vaccines to 170 countries, totalling more than 3.5 billion vaccine doses annually.^[10]

At least 15 manufacturer members have achieved WHO prequalification for their vaccines.^[9] Members are developing and producing novel vaccines for illnesses including

As of 2016, the timeline from a vaccine's first regulatory submission in its country of origin to its approval for use in Sub-Saharan Africa could take up to seven years.^[17][18] The DCVMN is active in identifying obstacles in the processes of vaccine registration and use. It works to increase coordination of requirements and procedures to improve the prequalification, procurement and supply of vaccines. This can involve governments in different countries, the World Health Organization (WHO), and United Nations agencies such as UNICEF.^[17][19][20]

The Developing Countries Vaccine Manufacturers Network has received funding from the Bill & Melinda Gates Foundation.^[5]

References